A national retrospective study of paediatric end-stage liver disease as a predictor of change to second-line therapy in children with autoimmune hepatitis.

Andréanne N ZizzoCarolina Jimenez-RiveraJoseph KimRichard A SchreiberSimon C LingJason YapJeff CritchNajma AhmedFernando AlvarezBinita M Kamathnull null

Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)

In this paediatric AIH cohort, higher PELD at presentation predicted change to second-line therapy within the first 2 years of follow-up. INR appeared to be the main contributor to that association.

Keyphrases

intensive care unit
emergency department
young adults
stem cells
quality improvement
case report
bone marrow
drug induced
smoking cessation
replacement therapy